Latest news with #Hydrochlorothiazide
Fox Sports
3 days ago
- Sport
- Fox Sports
Rockies pitcher Biembenido Brito and free agent outfielder Pablo Abad suspended for drug tests
Associated Press NEW YORK (AP) — Colorado Rockies minor league pitcher Biembenido Brito was suspended for 60 games and free agent outfielder Pablo Abad for 56 on Monday by Major League Baseball following positive tests for performance-enhancing substances. Brito tested positive for the performance-enhancing substance Stanozolol and for Hydrochlorothiazide, a diuretic and masking agent. He was disciplined under the minor league drug program, the commissioner's office said. Abad tested positive for Stanozolol and was penalized under the drug program for minor league players assigned outside the U.S. and Canada. Brito, a 22-year-old right-hander, agreed to a minor league contract with Texas in 2021 that included a $10,000 signing bonus. He was released by the Rangers in July 2024 and signed with the Rockies on May 23. He was 1-2 with a 2.97 ERA in seven starts and nine relief appearances for the rookie-level Arizona Complex League Rockies, striking out 38 and walking 18 in 33 1/3 innings. Brito is 6-7 with a 5.94 ERA in 19 starts and 31 relief appearances over parts of four minor league seasons. Abad, 19, signed with Cincinnati in June 2023 for a $10,000 bonus and was released last November. He hit .121 with one homer and six RBIs in 36 games over two seasons in the Dominican Summer League. Abad's suspension will start when he signs with a major league organization. Eleven players have been suspended this year for positive tests, including nine under minor league programs. Atlanta Braves outfielder Jurickson Profar was suspended for 80 games on March 31 and Philadelphia Phillies closer Jose Alvarado for 80 games on May 25 under the major league program. ___ AP MLB: recommended Item 1 of 1
Winnipeg Free Press
3 days ago
- Sport
- Winnipeg Free Press
Rockies pitcher Biembenido Brito and free agent outfielder Pablo Abad suspended for drug tests
NEW YORK (AP) — Colorado Rockies minor league pitcher Biembenido Brito was suspended for 60 games and free agent outfielder Pablo Abad for 56 on Monday by Major League Baseball following positive tests for performance-enhancing substances. Brito tested positive for the performance-enhancing substance Stanozolol and for Hydrochlorothiazide, a diuretic and masking agent. He was disciplined under the minor league drug program, the commissioner's office said. Abad tested positive for Stanozolol and was penalized under the drug program for minor league players assigned outside the U.S. and Canada. Brito, a 22-year-old right-hander, agreed to a minor league contract with Texas in 2021 that included a $10,000 signing bonus. He was released by the Rangers in July 2024 and signed with the Rockies on May 23. He was 1-2 with a 2.97 ERA in seven starts and nine relief appearances for the rookie-level Arizona Complex League Rockies, striking out 38 and walking 18 in 33 1/3 innings. Brito is 6-7 with a 5.94 ERA in 19 starts and 31 relief appearances over parts of four minor league seasons. Abad, 19, signed with Cincinnati in June 2023 for a $10,000 bonus and was released last November. He hit .121 with one homer and six RBIs in 36 games over two seasons in the Dominican Summer League. Abad's suspension will start when he signs with a major league organization. Eleven players have been suspended this year for positive tests, including nine under minor league programs. Atlanta Braves outfielder Jurickson Profar was suspended for 80 games on March 31 and Philadelphia Phillies closer José Alvarado for 80 games on May 25 under the major league program. ___ AP MLB:
CNN
18-07-2025
- Sport
- CNN
Women's marathon world record-holder Ruth Chepngetich provisionally suspended after testing positive for banned substance
Women's marathon world record-holder Ruth Chepngetich has been provisionally suspended after testing positive for a banned substance, the Athletics Integrity Unit (AIU) announced on Thursday. Chepngetich smashed the previous marathon record by almost two minutes when she ran a time of 2:09:56 at the Chicago Marathon in October 2024, becoming the first woman in history to break the 2:10 barrier. According to an AIU statement, the 30-year-old tested positive for Hydrochlorothiazide, a diuretic used clinically to treat fluid retention and hypertension, in a sample collected on March 14, which was then reported to the organization on April 3. Any levels of Hydrochlorothiazide below 20 ng/mL in urine are reported as negative. Chepngetich's sample had an estimated concentration of 3,800 ng/mL, the AIU said. Hydrochlorothiazide is prohibited at all times under the World Anti Doping Agency code and considered a 'Specified Substance,' which carries a standard sanction of two years. CNN Sports has reached out to Chepngetich's representative for comment. In the statement, AIU Head Brett Clothier said the organization notified Chepngetich in person on April 16 and 'complied with requests regarding our investigation.' Clothier added: 'Chepng'etich was not provisionally suspended by the AIU at the time of notification, however, on 19 April, she opted for a voluntary provisional suspension while the AIU's investigation was ongoing. 'In the intervening months, the AIU continued its investigation and (Thursday) issued a Notice of Charge and imposed its own provisional suspension.' In accordance with world anti-doping regulations, a provisional suspension from the AIU is not mandatory when there is a positive test for diuretics, which can be used to mask the presence of other banned substances in urine. 'Chepngetich has the right for her case to be heard before a Disciplinary Tribunal and that the AIU will not comment further until this matter has been concluded,' the statement concluded. Chepngetich is a three-time winner of the Chicago Marathon and took gold at the World Athletics Championships in 2019.
Mint
17-07-2025
- Sport
- Mint
Who is Ruth Chepngetich? Marathon world record holder suspended by Athletics Integrity Unit for doping
Ruth Chepngetich, the women's marathon world record holder, sent shockwaves across the athletics world on Thursday (July 17) when shewas provisionally banned by the Athletics Integrity Unit (AIU). The reason behind her suspension was testing positive for a banned substance. This development has sparked debate about her remarkable career and the integrity of elite marathon running. Ruth Chepngetich, a 30-year-old Kenyan runner, is one of the most celebrated long-distance athletes of her generation. In October 2024, she shattered the women's marathon world record at the Chicago Marathon, finishing in 2 hours, 9 minutes, and 56 seconds, nearly two minutes faster than the previous record set by Ethiopia's Tigst Assefa. This marked her third Chicago Marathon victory, leaving her mark as a dominant force. Chepngetich also won gold at the 2019 World Championships in Qatar, overcoming midnight heat to emerge victorious. Her achievements have made her a national hero in Kenya, a country renowned for its distance-running prowess, making her doping case all the more shocking. The doping substance detected in Chepngetich's March 14, 2025, sample was Hydrochlorothiazide (HCTZ), a diuretic used medically to treat fluid retention and hypertension. According to the AIU, the sample showed an HCTZ concentration of 3,800 ng/mL, far exceeding the World Anti-Doping Agency's (WADA) 20 ng/mL reporting threshold. HCTZ is prohibited in sports because it can act as a masking agent, increasing urine output to potentially dilute other banned substances, making them harder to detect. While not performance-enhancing, its presence raises concerns about possible attempts to conceal other doping violations, prompting scrutiny of Ruth Chepngetich's recent performances. Ruth Chepngetich was notified of the positive test on April 3 and voluntarily accepted a provisional suspension on April 19, halting her competitive activities. 'Chepngetich was not provisionally suspended by the AIU at the time of notification; however, on 19 April, she opted for a voluntary provisional suspension while the AIU's investigation was ongoing,' said AIU head Brett Clothier. On July 17, the AIU issued a formal Notice of Charge and imposed its own suspension. However, Ruth Chepngetich has the right to appeal and present her case before a Disciplinary Tribunal, which will determine her penalty, potentially a two-year ban.
USA Today
17-07-2025
- Sport
- USA Today
Marathon world record holder Ruth Chepngetich suspended over doping test
Ruth Chepngetich, the world record holder in the women's marathon, was provisionally suspended after a positive doping test. The Athletics Integrity Unit said Chepngetich tested positive for Hydrochlorothiazide (HCTZ), which is a diuretic used clinically to treat fluid retention and hypertension, from a sample collected from her on March 14. The AIU said Chepngetich, who is from Kenya, "opted for a voluntary provisional suspension while the AIU's investigation was ongoing." "When there is a positive test for diuretics and masking agents, a provisional suspension is not mandatory under the World Anti-Doping Code. Chepng'etich was not provisionally suspended by the AIU at the time of notification, however, on 19 April, she opted for a voluntary provisional suspension while the AIU's investigation was ongoing,' Athletics Integrity Unit head Brett Clothier said. Chepngetich, 30, set the world record during her third win in the Chicago Marathon in October, finishing in 2 hours, 9 minutes, 56 seconds. Chepngetich, who won the marathon at the 2019 world championships in Qatar, does have the right to appeal and to have her case heard before a disciplinary tribunal.
